End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.82 USD | -0.30% |
|
+0.64% | +5.30% |
06-11 | BofA Securities Adjusts Oculis Holding AG to $20 From $21, Maintains Buy Rating | MT |
06-11 | Baird Adjusts Price Target on Oculis Holding to $37 From $35, Maintains Outperform Rating | MT |
Chart calendar Oculis Holding AG
Upcoming events on Oculis Holding AG
Past events on Oculis Holding AG
2024-06-10 08:30 | Licaminlimab Phase 2B RELIEF Trial Results Call |
2024-05-29 09:30 | Annual General Meeting |
2024-05-15 14:20 | BofA Securities Health Care Conference |
2024-05-08 | Retina World Congress |
2024-05-08 16:10 | Q1 2024 Earnings Release |
2024-04-15 | Van Lanschot Kempen Life Sciences Conference |
2024-04-11 08:00 | Needham Healthcare Conference |
2024-04-06 | American Society of Cataract and Refractive Surgery Meeting |
2024-03-18 06:30 | Q4 2023 Earnings Release |
2024-03-13 10:40 | Leerink Partners Global Biopharma Conference |
2024-02-28 09:00 | R&D Day |
2024-02-08 05:40 | BioCapital Europe Conference |
2024-02-07 09:30 | Stifel Biotech Executive Summit |
2024-02-01 17:30 | Next Generation Ophthalmic Drug Delivery Summit |
2023-11-27 | Piper Sandler Healthcare Conference |
2023-11-27 09:00 | BTIG Ophthalmology Day |
2023-11-15 09:45 | Stifel Healthcare Conference |
2023-10-06 06:15 | Euretina Conference |
2023-09-14 08:10 | Pareto Securities HC Conference |
2023-09-11 08:30 | H.C. Wainwright Global Investment Conference |
Annual results
Fiscal Period | December | 2022 | 2023 | 2024 |
---|---|---|---|---|
Net sales Million CHF | Released Forecast Spread | 0,00 | 0,88 0,78 12.87% | 0,92 |
EBITDA Million CHF | Released Forecast Spread | 0,00 | -80,4 -60,3 -33.47% | -55,1 |
EBIT Million CHF | Released Forecast Spread | 0,00 | -80,7 -75,0 -7.67% | -59,6 |
Earnings before Tax (EBT) Million CHF | Released Forecast Spread | 0,00 | -88,7 -87,3 -1.57% | -59,8 |
Net income Million CHF | Released Forecast Spread | -38,7 | -88,8 -83,8 -5.92% | -61,6 |
EPS CHF | Released Forecast Spread | -12,9 | -2,97 -2,92 -1.59% | -1,70 |
Announcement Date | 28/03/23 | 18/03/24 | - |
Quarterly results
Fiscal Period | December | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2023 S2 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million CHF | Released Forecast Spread | 0,19 | 0,25 0,19 31.75% | 0,22 0,17 30.23% | 0,19 0,21 -11.49% | 0,22 0,26 -13.88% | 0,25 | 0,25 | 0,22 | 0,20 | 0,20 | ||
EBITDA Million CHF | Released Forecast Spread | -9,39 | -10,4 | -12,9 -9,18 -40.33% | -12,1 -12,7 4.31% | ||||||||
EBIT Million CHF | Released Forecast Spread | -9,57 | -10,7 -10,2 -5.77% | -13,0 -10,7 -21.57% | -12,2 -13,4 9.26% | -15,3 -13,8 -10.77% | -15,3 | -15,3 | -16,1 | ||||
Earnings before Tax (EBT) Million CHF | Released Forecast Spread | -11,1 | -12,8 -11,9 -7.48% | -17,5 -11,7 -49.93% | -12,5 -13,7 8.67% | -16,1 -13,1 -23.02% | -15,5 | -15,5 | -15,5 | ||||
Net income Million CHF | Released Forecast Spread | -9,78 | -12,9 -10,1 -26.87% | -17,4 -11,3 -53.72% | -12,5 -14,6 14.18% | -16,1 -13,6 -18.44% | -15,2 | -15,4 | -15,9 | ||||
EPS CHF | Released Forecast Spread | -0,30 | -0,38 -0,29 -28.91% | -2,53 -0,51 -396.08% | -0,48 -0,33 -46.75% | -0,34 -0,40 15.11% | -0,48 | -0,44 -0,37 -18.28% | -0,41 | -0,43 | -0,44 | -0,37 | -0,37 |
Announcement Date | - | 29/08/23 | 29/08/23 | 15/11/23 | 18/03/24 | - | 08/05/24 | - | - | - | - | - |
2024-07-15 01:45 | ADDLIFE AB: Q2 2024 Earnings Release |
2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
2024-07-25 01:00 | BACHEM HOLDING AG: Q2 2024 Earnings Release |
2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
2024-07-26 01:00 | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Oculis Holding AG
2024-06-07 02:57 | POLARIS GROUP: May 2024 Sales and Revenue Release |
2024-05-29 16:01 | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
2024-05-23 07:00 | CUREVAC N.V.: Q1 2024 Earnings Release |
2024-05-22 01:00 | EVOTEC SE: Q1 2024 Earnings Release |
2024-05-21 17:14 | ALVOTECH: Q1 2024 Earnings Release |
2024-05-21 07:00 | EXSCIENTIA PLC: Q1 2024 Earnings Release |
2024-05-17 02:00 | BIOARCTIC AB: Q1 2024 Earnings Release |
2024-05-15 16:05 | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- OCS Stock
- Calendar Oculis Holding AG